Cargando…
Metronidazole-Induced Encephalopathy in a Patient with End-Stage Liver Disease
Purpose. Metronidazole-induced encephalopathy (MIE) has been rarely reported. We report a case in a patient with end-stage liver disease (ESLD). Summary. A 63-year-old male with ESLD secondary to hepatitis C virus presented with progressively worsening fatigue, slurred speech, aphasia, vomiting, and...
Autores principales: | Knorr, John P., Javed, Imran, Sahni, Neha, Cankurtaran, Ceylan Z., Ortiz, Jorge A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4208391/ https://www.ncbi.nlm.nih.gov/pubmed/25374704 http://dx.doi.org/10.1155/2012/209258 |
Ejemplares similares
-
Metronidazole-induced encephalopathy
por: Lala, Vikash G., et al.
Publicado: (2021) -
Metronidazole-induced encephalopathy in a patient with liver cirrhosis
por: Cheong, Hyeong Cheol, et al.
Publicado: (2011) -
Metronidazole‐induced encephalopathy associated with treatment for liver abscesses
por: Hanji, Yurika, et al.
Publicado: (2017) -
Metronidazole-induced Encephalopathy
por: Phyu, Htay, et al.
Publicado: (2019) -
Metronidazole-induced encephalopathy in a patient with cirrhosis
por: Ji, Xinyu, et al.
Publicado: (2023)